Revvity, Inc. (BIT:1RVTY)

Market Cap	9.01B
Revenue (ttm)	2.39B
Net Income (ttm)	243.42M
Shares Out	n/a
EPS (ttm)	2.02
PE Ratio	37.01
Forward PE	17.67
Dividend	0.19 (0.26%)
Ex-Dividend Date	Jul 17, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	74.86
Day's Range	n/a
52-Week Range	73.76 - 88.45
Beta	n/a
RSI	42.10
Earnings Date	Jul 31, 2025

About Heartland Financial USA

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company’s Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for tes...

• Industry: Laboratory Analytical Instruments
• Founded: 1937
• Employees: 11,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1RVTY

Financial Performance

In 2024, Revvity's revenue was $2.76 billion, an increase of 0.16% compared to the previous year's $2.75 billion. Earnings were $270.39 million, a decrease of -60.99%.